203 related articles for article (PubMed ID: 1945879)
1. One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter.
Briegel K; Hentsch B; Pfeuffer I; Serfling E
Nucleic Acids Res; 1991 Nov; 19(21):5929-36. PubMed ID: 1945879
[TBL] [Abstract][Full Text] [Related]
2. An NF-kappa B-like element plays an essential role in interleukin-1-mediated costimulation of the mouse interleukin-2 promoter.
Stricker K; Serfling E; Krammer PH; Falk W
Eur J Immunol; 1993 Jul; 23(7):1475-80. PubMed ID: 8325323
[TBL] [Abstract][Full Text] [Related]
3. The weak, fine-tuned binding of ubiquitous transcription factors to the Il-2 enhancer contributes to its T cell-restricted activity.
Hentsch B; Mouzaki A; Pfeuffer I; Rungger D; Serfling E
Nucleic Acids Res; 1992 Jun; 20(11):2657-65. PubMed ID: 1614851
[TBL] [Abstract][Full Text] [Related]
4. Activation of interleukin-2 gene transcription via the T-cell surface molecule CD28 is mediated through an NF-kB-like response element.
Verweij CL; Geerts M; Aarden LA
J Biol Chem; 1991 Aug; 266(22):14179-82. PubMed ID: 1650350
[TBL] [Abstract][Full Text] [Related]
5. Activation of the IL-2 gene promoter by HTLV-I tax involves induction of NF-AT complexes bound to the CD28-responsive element.
Good L; Maggirwar SB; Sun SC
EMBO J; 1996 Jul; 15(14):3744-50. PubMed ID: 8670878
[TBL] [Abstract][Full Text] [Related]
6. Ubiquitous and lymphocyte-specific factors are involved in the induction of the mouse interleukin 2 gene in T lymphocytes.
Serfling E; Barthelmäs R; Pfeuffer I; Schenk B; Zarius S; Swoboda R; Mercurio F; Karin M
EMBO J; 1989 Feb; 8(2):465-73. PubMed ID: 2542017
[TBL] [Abstract][Full Text] [Related]
7. An enhancer element 6 kb upstream of the mouse HNF4alpha1 promoter is activated by glucocorticoids and liver-enriched transcription factors.
Bailly A; Torres-Padilla ME; Tinel AP; Weiss MC
Nucleic Acids Res; 2001 Sep; 29(17):3495-505. PubMed ID: 11522818
[TBL] [Abstract][Full Text] [Related]
8. Purification of TCF-1 alpha, a T-cell-specific transcription factor that activates the T-cell receptor C alpha gene enhancer in a context-dependent manner.
Waterman ML; Jones KA
New Biol; 1990 Jul; 2(7):621-36. PubMed ID: 2083253
[TBL] [Abstract][Full Text] [Related]
9. Regulation of cell-type-specific interleukin-2 receptor alpha-chain gene expression: potential role of physical interactions between Elf-1, HMG-I(Y), and NF-kappa B family proteins.
John S; Reeves RB; Lin JX; Child R; Leiden JM; Thompson CB; Leonard WJ
Mol Cell Biol; 1995 Mar; 15(3):1786-96. PubMed ID: 7862168
[TBL] [Abstract][Full Text] [Related]
10. HMG I(Y) interferes with the DNA binding of NF-AT factors and the induction of the interleukin 4 promoter in T cells.
Klein-Hessling S; Schneider G; Heinfling A; Chuvpilo S; Serfling E
Proc Natl Acad Sci U S A; 1996 Dec; 93(26):15311-6. PubMed ID: 8986808
[TBL] [Abstract][Full Text] [Related]
11. A novel T-cell trans-activator that recognizes a phorbol ester-inducible element of the interleukin-2 promoter.
Radler-Pohl A; Pfeuffer I; Karin M; Serfling E
New Biol; 1990 Jun; 2(6):566-73. PubMed ID: 2088505
[TBL] [Abstract][Full Text] [Related]
12. Positive and negative regulation of IL-2 gene expression: role of multiple regulatory sites.
Zhang L; Nabel GJ
Cytokine; 1994 May; 6(3):221-8. PubMed ID: 8054477
[TBL] [Abstract][Full Text] [Related]
13. The c-rel protooncogene product represses NF-kappa B p65-mediated transcriptional activation of the long terminal repeat of type 1 human immunodeficiency virus.
Doerre S; Sista P; Sun SC; Ballard DW; Greene WC
Proc Natl Acad Sci U S A; 1993 Feb; 90(3):1023-7. PubMed ID: 8430069
[TBL] [Abstract][Full Text] [Related]
14. [Regulation of transcription of the interleukin-2 gene in B-lymphocytes].
Mouzaki A; Zubler RH
Schweiz Med Wochenschr; 1995 Mar; 125(9):396-9. PubMed ID: 7892566
[TBL] [Abstract][Full Text] [Related]
15. The kappa B enhancer of the human interleukin-6 promoter is necessary and sufficient to confer an IL-1 beta and TNF-alpha response in transfected human cell lines: requirement for members of the C/EBP family for activity.
Merola M; Blanchard B; Tovey MG
J Interferon Cytokine Res; 1996 Oct; 16(10):783-98. PubMed ID: 8910763
[TBL] [Abstract][Full Text] [Related]
16. Nuclear appearance of a factor that binds the CD28 response element within the interleukin-2 enhancer correlates with interleukin-2 production.
Civil A; Bakker A; Rensink I; Doerre S; Aarden LA; Verweij CL
J Biol Chem; 1996 Apr; 271(14):8321-7. PubMed ID: 8626528
[TBL] [Abstract][Full Text] [Related]
17. Chromatin remodeling of the interleukin-2 gene: distinct alterations in the proximal versus distal enhancer regions.
Ward SB; Hernandez-Hoyos G; Chen F; Waterman M; Reeves R; Rothenberg EV
Nucleic Acids Res; 1998 Jun; 26(12):2923-34. PubMed ID: 9611237
[TBL] [Abstract][Full Text] [Related]
18. Multiple signals are required for function of the human granulocyte-macrophage colony-stimulating factor gene promoter in T cells.
Jenkins F; Cockerill PN; Bohmann D; Shannon MF
J Immunol; 1995 Aug; 155(3):1240-51. PubMed ID: 7636192
[TBL] [Abstract][Full Text] [Related]
19. NF-kappa B site-mediated negative regulation of the HIV-1 promoter by CCAAT/enhancer binding proteins in brain-derived cells.
Mondal D; Alam J; Prakash O
J Mol Neurosci; 1994-1995; 5(4):241-58. PubMed ID: 7577367
[TBL] [Abstract][Full Text] [Related]
20. Involvement of CCAAT/enhancer-binding protein and nuclear factor-kappa B binding sites in interleukin-6 promoter inhibition by estrogens.
Galien R; Evans HF; Garcia T
Mol Endocrinol; 1996 Jun; 10(6):713-22. PubMed ID: 8776731
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
